Dr. Ehsan Shabbir, MD

Dr. Shabbir practices at Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare.

Dr. Shabbir's NPI, 1518309616, was assigned on July 18, 2013. Dr. Shabbir holds Ohio license 35.134743.

Dr. Shabbir's primary practice is Kettering Health Dayton, at 405 Grand Avenue, Dayton, OH 45405 in Montgomery County. The practice phone is (937) 723-3410.

Dr. Shabbir's primary practice is Kettering Health Dayton in Dayton, Ohio, part of Kettering Adventist Healthcare. Dr. Shabbir is also affiliated with Miami Valley Hospital. The medical group on file is Kettering Health Medical Group. Dmand AI also links Dr. Shabbir to 3 more hospitals, 6 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shabbir practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shabbir's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Shabbir's licenses on file in 3 states: Ohio, District of Columbia and Iowa.

CMS data shows 642 Medicare services from Dr. Shabbir across 4 procedure codes in 2024, for 269 Medicare patients. Medicare paid $51,313 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 269 Medicare patients who saw Dr. Shabbir in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shabbir's median patient age at 69, with 51% women.

In 2024, Dr. Shabbir wrote 283 Medicare Part D claims for 123 patients. 89% of them were for generic drugs. CMS names the drug for 84 of them, across 6 drugs with 11 or more claims each, at $7,963 in total drug cost. In 2023, CMS named 125 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Shabbir for performance year 2024, reported as part of a group. Dr. Shabbir accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Shabbir, published from 2020 to 2023. 2023 was the busiest year, with 2. Dr. Shabbir has published most often in Cureus. Dr. Shabbir's most frequent co-authors are Umar Farooq, MD, Mustafa N. Musleh, MD and Hassan B. Alkhateeb, MD.

CMS Open Payments shows 2 general payments to Dr. Shabbir from 2 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Astellas Pharma US Inc paid the most, $129.